Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Buy
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Ginkgo Bioworks Holdings, Inc. (DNA)
Biological Products, (no Disgnostic Substances)
https://www.ginkgobioworks.com
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.
27 DRYDOCK AVENUE, 8TH FLOOR
BOSTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/19/2021
Market Cap
477,281,388
Shares Outstanding
1,619,440,000
Weighted SO
2,118,436,556
Total Employees
N/A
Upcoming Earnings
08/14/2024
Similar Tickers
Beta
1.1470
Last Div
0.0000
Range
0.21-2.465
Chg
-0.0399
Avg Vol
55689512
Mkt Cap
477281388
Exch
NYSE
Country
US
Phone
877 422 5362
DCF Diff
N/A
DCF
0.0000
Div Yield
0.0000
P/S
2.5892
EV Multiple
-0.4281
P/FV
0.5296
Div Yield %
0.0000
P/E
-0.4915
PEG
-0.0134
Payout
-0.0006
Current Ratio
4.7147
Quick Ratio
4.7147
Cash Ratio
4.4099
DSO
37.4059
DIO
0.0000
Op Cycle
37.4059
DPO
110.6100
CCC
-73.2041
Gross Margin
0.5877
Op Margin
-4.0693
Pretax Margin
-4.8698
Net Margin
-4.8698
Eff Tax Rate
0.0000
ROA
-0.5523
ROE
-0.8610
ROCE
-0.5141
NI/EBT
1.0000
EBT/EBIT
1.1967
EBIT/Rev
-4.0693
Debt Ratio
0.2783
D/E
0.5429
LT Debt/Cap
0.3519
Total Debt/Cap
0.3519
Int Coverage
-8065.7419
CF/Debt
-0.6539
Equity Multi
1.9509
Rec Turnover
9.7578
Pay Turnover
3.2999
Inv Turnover
0.0000
FA Turnover
0.2933
Asset Turnover
0.1134
OCF/Share
-0.1439
FCF/Share
-0.1642
Cash/Share
0.3566
OCF/Sales
-1.6044
FCF/OCF
1.1406
CF Coverage
-0.6539
ST Coverage
0.0000
CapEx Coverage
-7.1148
Div&CapEx Cov
-7.0212
P/BV
0.5296
P/B
0.5296
P/S
2.5892
P/E
-0.4915
P/FCF
-1.4149
P/OCF
-1.4917
P/CF
-1.4917
PEG
-0.0134
P/S
2.5892
EV Multiple
-0.4281
P/FV
0.5296
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
26.56M Shares Bought (87.86 %)
3.67M Shares Sold (12.14%)
3 - 6 Months
1.66M Shares Bought (74.12 %)
578.02K Shares Sold (25.88%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2020 | 2022 | 2022 | 2023 | 2024 | 2024 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 32.06M | ▲ 148.49M | ▼ 66.40M | ▲ 98.29M | ▼ 34.76M | ▲ 37.94M | ▼ |
Cost Of Revenue | 13.84M | ▲ 66.58M | ▼ 2.66M | ▲ 30.22M | ▼ 15.95M | ▲ 22.07M | ▼ |
Gross Profit | 18.22M | ▲ 81.92M | ▼ 63.74M | ▲ 68.07M | ▼ 18.81M | ▼ 15.87M | ▼ |
Gross Profit Ratio | 0.57 | ▼ 0.55 | ▲ 0.96 | ▼ 0.69 | ▼ 0.54 | ▼ 0.42 | ▼ |
Research And Development Expenses | 61.19M | ▲ 985.03M | ▼ 259.58M | ▼ 181.16M | ▼ 107.70M | ▲ 123.59M | ▼ |
General And Administrative Expenses | 12.91M | ▲ 781.63M | ▼ 435.18M | ▼ 121.42M | ▼ 89.22M | ▼ 70.29M | ▼ |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -23.66M | ▲ -19.27M | ▼ |
Selling General And Administrative Expenses | 12.91M | ▲ 781.63M | ▼ 435.18M | ▼ 121.42M | ▼ 65.56M | ▼ 51.02M | ▼ |
Other Expenses | 1.78M | ▼ -1.62M | ▲ 24.66M | ▼ 7.01M | ▼ 93.00K | ▲ 2.02M | ▼ |
Operating Expenses | 74.10M | ▲ 1.77B | ▼ 719.42M | ▼ 302.58M | ▼ 173.26M | ▲ 174.61M | ▼ |
Cost And Expenses | 87.95M | ▲ 1.83B | ▼ 722.08M | ▼ 332.79M | ▼ 189.21M | ▲ 196.68M | ▼ |
Interest Income | -2.98M | ▲ 496.00K | ▼ 0.00 | ▲ 13.06M | ▲ 13.30M | ▼ 11.71M | ▼ |
Interest Expense | 590.00K | ▼ 551.00K | ▲ 5.82M | ▲ 13.06M | ▼ 93.00K | ▼ 0.00 | |
Depreciation And Amortization | 4.00M | ▲ 8.00M | ▼ 0.00 | ▲ 304.00K | ▲ 12.84M | ▲ 12.87M | ▼ |
Ebitda | -51.33M | ▼ -1.69B | ▲ -653.02M | ▲ -234.20M | ▲ -141.62M | ▼ -145.87M | ▼ |
Ebitda Ratio | -1.60 | ▼ -11.38 | ▲ -9.83 | ▲ -2.38 | ▼ -4.07 | ▲ -3.84 | ▼ |
Operating Income | -55.89M | ▼ -1.68B | ▲ -653.02M | ▲ -234.51M | ▲ -154.45M | ▼ -158.74M | ▼ |
Operating Income Ratio | -1.74 | ▼ -11.35 | ▲ -9.83 | ▲ -2.39 | ▼ -4.44 | ▲ -4.18 | ▼ |
Total Other Income Expenses Net | 13.07M | ▲ 79.11M | ▼ -16.06M | ▲ 45.58M | ▼ -57.44M | ▲ -7.14M | ▼ |
Income Before Tax | -46.39M | ▼ -1.61B | ▲ -669.08M | ▲ -188.92M | ▼ -211.89M | ▲ -165.88M | ▼ |
Income Before Tax Ratio | -1.45 | ▼ -10.81 | ▲ -10.08 | ▲ -1.92 | ▼ -6.10 | ▲ -4.37 | ▼ |
Income Tax Expense | 8.00K | ▼ -683.00K | ▲ -28.00K | ▼ -14.77M | ▲ -198.00K | ▲ 31.00K | ▼ |
Net Income | -46.92M | ▼ -1.60B | ▲ -669.06M | ▲ -174.15M | ▼ -211.69M | ▲ -165.91M | ▼ |
Net Income Ratio | -1.46 | ▼ -10.78 | ▲ -10.08 | ▲ -1.77 | ▼ -6.09 | ▲ -4.37 | ▼ |
Eps | -0.03 | ▼ -1.05 | ▲ 0.00 | ▼ -0.09 | ▼ -0.11 | ▲ -0.08 | ▼ |
Eps Diluted | -0.03 | ▼ -1.05 | ▲ 0.00 | ▼ -0.09 | ▼ -0.11 | ▲ -0.08 | ▼ |
Weighted Average Shs Out | 1.49B | ▲ 1.53B | ▲ 1.63T | ▼ 1.85B | ▲ 1.98B | ▲ 2.00B | ▼ |
Weighted Average Shs Out Dil | 1.49B | ▲ 1.53B | ▲ 1.63T | ▼ 1.85B | ▲ 1.98B | ▲ 2.00B | ▼ |